At a recent ECVA
M workshop considering ways to reduce the frequency of irrelevant positive results in
ma
mmalian cell genotoxicity tests [D. Kirkland, S. Pfuhler, D. Tweats, M. Aarde
ma, R. Corvi, F. Darroudi, A. Elhajouji, H.-R. Glatt, P. Hastwell, M. Hayashi, P. Kasper, S. Kirchner, A. Lynch, D. Marzin, D. Maurici, J.-R. Meunier, L. Müller, G. Nohynek, J.
Parry, E. Parry, V. Thybaud, R. Tice, J. van Benthe
m, P. Vanparys, P. White, How to reduce false positive results when undertaking
in vitro genotoxicity testing and thus avoid unnecessary followup ani
mal tests: Report of an ECVAM Workshop, Mutat. Res. 628 (2007) 31–55], reco
mmendations for i
mprove
ments/
modifications to existing tests, and suggestions for new assays were
made. Following on fro
m this, it was i
mportant to identify che
micals that could be used in the evaluation of
modified or new assays. An expert panel was therefore convened and reco
mmendations
made for che
micals to fit three different sets of characteristics, na
mely:
- Group 1: Chemicals that should be detected as positive in in vitro mammalian cell genotoxicity tests. Chemicals in this group are all in vivo genotoxins, either due to DNA-reactive or non DNA-reactive mechanisms (e.g., induction of aneuploidy, inhibition of topoisomerase). Most of them are also known carcinogens with a mutagenic mode of action.